Search
for

    Research

    5 / 177 results
      Hormonal, Medical, and Nonsurgical Aspects of Gender Affirmation

      research Hormonal, Medical, and Nonsurgical Aspects of Gender Affirmation

      5 citations , March 2019 in “Facial Plastic Surgery Clinics of North America”
      In this article, the authors reviewed essential terminology and recommendations for creating a welcoming healthcare environment for transgender patients and providing gender-affirming therapy, emphasizing the unique health needs and disparities faced by this population.
      Navigating the Intersection of Hormonal Therapy and Acne Management in Trans Youth

      research Navigating the Intersection of Hormonal Therapy and Acne Management in Trans Youth

      January 2025 in “ARC Journal of Dermatology”
      This study discusses the importance of careful dermatological care for transgender youth receiving hormonal therapies, cautioning that acne treatments can interfere with hormone replacement therapy and emphasizing the need for a collaborative interdisciplinary approach to support both acne management and overall well-being.
      Effects of Hormonal Therapy in Transgenders

      research EFFECTS OF HORMONAL THERAPY IN TRANSGENDERS

      July 2024 in “Biological and Clinical Sciences Research Journal”
      This review reports that transgender individuals undergoing hormonal therapy for gender transition face increased risks of cardiovascular disorders, brain tumors, changes in bone density, metabolic disorders, and other health issues, while highlighting the necessity of this therapy for gender transformation.

    Community Join

    4 / 1000+ results

    Learn

    5 / 801 results

      learn Clascoterone

      a novel topical treatment that inhibits DHT on androgen receptors
      • Can I use clascoterone if I'm undergoing gender-affirming hormone therapy? No published clinical trial has tested clascoterone in people on gender-affirming hormone therapy, so its safety in that group is unknown. The FDA label reports low systemic exposure and no described effect on blood testosterone, but it also records HPA-axis suppression and raised potassium in a small minority of subjects.

      learn Pyrilutamide

      highly targeted anti-androgen that might have minimal systemic effects

      learn Bicalutamide

      a nonsteroidal anti-androgen, most commonly used orally for women

      learn Cyproterone

      a synthetic anti-androgen and weak progestogen that inhibits DHT binding to androgen receptor

      learn Spironolactone

      powerful topical and oral anti-androgen used mostly by women